What is BioQ Pharma?
BioQ Pharma is a commercial-stage company dedicated to revolutionizing the administration of infusible medicines. Their proprietary platform is engineered to create connect-and-go systems, thereby improving the efficacy, safety, and user-friendliness of drug delivery for patients, healthcare providers, and payers alike. The company specializes in developing bespoke, pre-filled, and adaptable delivery solutions tailored to specific dosing requirements, with a particular emphasis on challenging-to-administer infusible drugs. BioQ Pharma's patented technology is already deployed for various infusible drugs, focusing on streamlining the administration process and bolstering safety protocols.
How much funding has BioQ Pharma raised?
BioQ Pharma has raised a total of $53.7M across 5 funding rounds:
Debt
$13.7M
Private Equity
$18.3M
Debt
$15M
Private Equity
$6.3M
Debt
$350K
Debt (2014): $13.7M, investors not publicly disclosed
Private Equity (2015): $18.3M, investors not publicly disclosed
Debt (2016): $15M, investors not publicly disclosed
Private Equity (2017): $6.3M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
Key Investors in BioQ Pharma
PPP
Public-Private Partnership
What's next for BioQ Pharma?
The substantial enterprise-level funding and recent strategic investment position BioQ Pharma for accelerated growth and market penetration. This capital infusion is expected to fuel further development of their innovative drug delivery systems, potentially expanding their portfolio to address a wider range of therapeutic areas. The company's focus on enhancing the simplicity and safety of infusible medicine delivery aligns with a growing market demand for more patient-centric healthcare solutions. BioQ Pharma is poised to leverage this financial backing to scale its operations, forge new partnerships, and solidify its standing as a leader in advanced drug delivery technology.
See full BioQ Pharma company page
